Role of tissue factor in embryonic blood vessel development, Nature, vol.383, issue.6595, pp.73-75, 1996. ,
DOI : 10.1038/383073a0
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.1545-1550, 2005. ,
DOI : 10.1161/01.ATV.0000171155.05809.bf
The Role of Tissue Factor and Factor VIIa in Hemostasis, Anesthesia & Analgesia, vol.108, issue.5, pp.1447-1452, 2009. ,
DOI : 10.1213/ane.0b013e31819bceb1
The relationship between tissue factor and cancer progression: insights from bench and bedside, Blood, vol.119, issue.4, pp.924-932, 2012. ,
DOI : 10.1182/blood-2011-06-317685
Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor kappa B, and Egr-1, Journal of Biological Chemistry, vol.277, issue.28, pp.25032-25039, 2002. ,
DOI : 10.1074/jbc.M204003200
MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells, Journal of Biological Chemistry, vol.286, issue.2, pp.1429-1435, 2011. ,
DOI : 10.1074/jbc.M110.146530
Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis, Blood, vol.105, issue.4, pp.1734-1775, 2005. ,
DOI : 10.1182/blood-2004-05-2042
Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity, Cancer Research, vol.69, issue.6, pp.2540-2549, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-1547
Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway, Molecular Carcinogenesis, vol.9, issue.4, pp.234-243, 1998. ,
DOI : 10.1002/(SICI)1098-2744(199804)21:4<234::AID-MC2>3.0.CO;2-K
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001. ,
DOI : 10.1182/blood.V98.5.1429
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications, Circulation, vol.113, issue.5, pp.722-731, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.105.567297
Alternatively spliced tissue factor. A crippled protein in coagulation ora key player in non haemostatic processes, Hamostaseologie, vol.30, pp.144-149, 2010. ,
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein, Nature Medicine, vol.9, issue.4, pp.458-462, 2003. ,
DOI : 10.1038/nm841
Alternatively spliced Tissue Factor: discovery, insights, clinical implications, Frontiers in Bioscience, vol.16, issue.1, pp.3061-3071, 2011. ,
DOI : 10.2741/3899
Role of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Regulating Alternative Splicing of Tissue Factor mRNA in Human Endothelial Cells, Circulation Journal, vol.73, issue.9, pp.1746-1752, 2009. ,
DOI : 10.1253/circj.CJ-99-0225
Alternatively spliced tissue factor induces angiogenesis through integrin ligation, Proceedings of the National Academy of Sciences, vol.106, issue.46, pp.19497-19502, 2009. ,
DOI : 10.1073/pnas.0905325106
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model, Thrombosis Research, vol.120, pp.13-21, 2007. ,
DOI : 10.1016/S0049-3848(07)70126-3
Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis, Oncology Reports, vol.20, pp.123-128, 2008. ,
DOI : 10.3892/or.20.1.123
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration, Br J Cancer, vol.83, pp.164-170, 2000. ,
PML/RAR?? fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association, Proceedings of the National Academy of Sciences, vol.107, issue.8, pp.3716-3721, 2010. ,
DOI : 10.1073/pnas.0915006107
Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy, Journal of the American College of Cardiology, vol.45, issue.7, pp.1081-1090, 2005. ,
DOI : 10.1016/j.jacc.2004.12.061
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells, Oncogene, vol.6, issue.35, pp.4947-4958, 2010. ,
DOI : 10.1038/onc.2010.240
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health, Oncotarget, vol.2, issue.3, pp.135-164, 2011. ,
DOI : 10.18632/oncotarget.240
PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.10, pp.1963-1969, 2004. ,
DOI : 10.1161/01.ATV.0000143096.15099.ce
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001. ,
DOI : 10.1182/blood.V98.5.1429
Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells, Journal of Biological Chemistry, vol.286, issue.30, pp.27027-27038, 2011. ,
DOI : 10.1074/jbc.M111.235176
Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling, Genes to Cells, vol.276, issue.9, pp.941-947, 2008. ,
DOI : 10.1111/j.1365-2443.2008.01218.x
Targeting Cancer with Small-Molecular-Weight Kinase Inhibitors, Methods Mol Biol, vol.795, pp.1-34, 2012. ,
DOI : 10.1007/978-1-61779-337-0_1
Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells, Acta Biochim Pol, vol.58, pp.391-396, 2011. ,
Anthrax infection inhibits the AKT signaling involved in the E-cadherin-mediated adhesion of lung epithelial cells, FEMS Immunology & Medical Microbiology, vol.56, issue.2, pp.129-142, 2009. ,
DOI : 10.1111/j.1574-695X.2009.00558.x
Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells, Journal of Leukocyte Biology, vol.87, issue.1, pp.147-152, 2010. ,
DOI : 10.1189/jlb.0409252
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Advan Enzyme Regul, pp.249-279, 2006. ,
EGFR Signaling and Drug Discovery, Oncology, vol.77, issue.6, pp.400-410, 2009. ,
DOI : 10.1159/000279388
Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells, Journal of Hematology & Oncology, vol.5, issue.1, p.16, 2012. ,
DOI : 10.1159/000279388
URL : https://hal.archives-ouvertes.fr/inserm-00716982